ecrin-mdr-crcClinical2006Colorectal NeoplasmsCancerColorectal NeoplasmsCancerInterventionalhttps://newmdr.ecrin.org/Study/2028571United States4Initial therapyOxaliplatinColorectalCapecitabineMetastaticCetuximabBevacizumabECRIN MDRTerminatedfalseCombination of Cetuximab, Capecitabine, and Oxaliplatin With or Without BevacizumabThe purpose of this study is to determine the objective response rate of patients with previously untreated metastatic colorectal cancer treated with the combination of cetuximab, capecitabine, and oxaliplatin with out without bevacizumab.2006-04-152028571NCT00321100